Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Mandrup-Poulsen

Showing results (1-10 of 126) with videos related to

Pageof 13
Sort By:
Biochemical Pharmacology|October 14, 2003
Apoptotic signal transduction pathways in diabetesThomas Mandrup-Poulsen
Expert Opinion on Investigational Drugs|May 28, 2013
Interleukin-1 antagonists for diabetesThomas Mandrup-Poulsen,
Dermatologic Clinics|July 6, 2013
Type 2 diabetes mellitus: a metabolic autoinflammatory diseaseThomas Mandrup-Poulsen
The Review of Diabetic Studies : RDS|June 28, 2013
Interleukin-1 antagonists and other cytokine blockade strategies for type 1 diabetesThomas Mandrup-Poulsen
Annals of the New York Academy of Sciences|December 18, 2003
Beta cell death and protectionThomas Mandrup-Poulsen
Diabetes|November 25, 2005
Interleukin-6 and diabetes: the good, the bad, or the indifferent?Ole P Kristiansen, Thomas Mandrup-Poulsen
Ugeskrift for Laeger|June 21, 2008
[Treatment of diabetes mellitus with biologic therapeutics]Claus Morten Larsen, Thomas Mandrup-Poulsen
Seminars in Immunopathology|April 27, 2019
Treatment of type 2 diabetes by targeting interleukin-1: a meta-analysis of 2921 patientsYachana Kataria, Christina Ellervik, Thomas Mandrup-Poulsen
Clinical Immunology (Orlando, Fla.)|March 21, 2013
Anti-cytokine therapies in T1D: Concepts and strategiesGerald T Nepom, Mario Ehlers, Thomas Mandrup-Poulsen
Nature Reviews. Endocrinology|February 23, 2010
Blockade of interleukin 1 in type 1 diabetes mellitusThomas Mandrup-Poulsen, Linda Pickersgill, Marc Yves Donath
Pageof 13

Showing results (1-10 of 126) with videos related to

Sort By:
Pageof 13
Biochemical Pharmacology|October 14, 2003
Apoptotic signal transduction pathways in diabetesThomas Mandrup-Poulsen
Expert Opinion on Investigational Drugs|May 28, 2013
Interleukin-1 antagonists for diabetesThomas Mandrup-Poulsen,
Dermatologic Clinics|July 6, 2013
Type 2 diabetes mellitus: a metabolic autoinflammatory diseaseThomas Mandrup-Poulsen
The Review of Diabetic Studies : RDS|June 28, 2013
Interleukin-1 antagonists and other cytokine blockade strategies for type 1 diabetesThomas Mandrup-Poulsen
Annals of the New York Academy of Sciences|December 18, 2003
Beta cell death and protectionThomas Mandrup-Poulsen
Diabetes|November 25, 2005
Interleukin-6 and diabetes: the good, the bad, or the indifferent?Ole P Kristiansen, Thomas Mandrup-Poulsen
Ugeskrift for Laeger|June 21, 2008
[Treatment of diabetes mellitus with biologic therapeutics]Claus Morten Larsen, Thomas Mandrup-Poulsen
Seminars in Immunopathology|April 27, 2019
Treatment of type 2 diabetes by targeting interleukin-1: a meta-analysis of 2921 patientsYachana Kataria, Christina Ellervik, Thomas Mandrup-Poulsen
Clinical Immunology (Orlando, Fla.)|March 21, 2013
Anti-cytokine therapies in T1D: Concepts and strategiesGerald T Nepom, Mario Ehlers, Thomas Mandrup-Poulsen
Nature Reviews. Endocrinology|February 23, 2010
Blockade of interleukin 1 in type 1 diabetes mellitusThomas Mandrup-Poulsen, Linda Pickersgill, Marc Yves Donath
Pageof 13